REMINDER: Our user survey closes TODAY, please submit your responses here.
Rabnesbit.. wise to keep your options ... but its worth considering the IPO was at 5p hence giving OCTP a valve where the markets believe was fair at that time.
Since then OCTP have plenty other products in the pipe line and at 0.8p is I believe a good entry. If the progress of the trials go to plan as OCTP think they are then I would expect as you stated a buyout but probably OCTP would franchise their patent as this would give infinite revenue or a JV
Again GL with your decision
Fully funded till April 2024, £5m cash in bank
most of OCTP products are being tested for the certificate of approval via pharmacist and prescriptions . Hence these trials are no longer than 12 weeks. Q3 are results so any time now.
Cannabis are widely used for pain killers and other uses which you can buy by other means and has been self proved that these do work.
OCTP have taken the route to actually certify these uses and will patent their products so they could be sold worldwide
As cannabis been widely used for all purposes for humans for some time now we would of known of any serious side effect
The fact it's been available off counter without real licensing confirms its fairly safe to use.
OCTP are just legally licence this to be used prescribed methods which will be used as alternative natural medicines by our GP's world over
Having checked the last 2 weeks volume my data shows most of the trades showing as sells are actually buys. Must be an accumulative buying order at this price which are being hidden - Are we expecting a tr1 announcing buyer /seller
My money would be someone is accumulating all these shares prior to results
Can anyone establish the recent constant low amount of sells showing 0.855 & 0.856 are actually buys ? other than the obvious very low amount of small buys at 0.9 which the mm's seem reluctant to drop.
My trading platform say differ 0.856 buys and 0.850 to sell
A little patience is required and OCTP is still under the radar as most investors are busy day trading. There has been plenty of buys shown as sells during the last few weeks and anticipate a positive upward trend on the next rns. By that time the sp should jump to 1.3 - 1.5p or more. These trial results can land at any time as mention the time frame is about 12 weeks only.
So any time now Q3
The proceeds from the Placing will be used by Tower to fund work programme commitments in respect of its licenses in Cameroon, Namibia and South Africa as well as for general working capital purposes.
Jeremy Asher, Tower's Chairman and CEO, commented:
"We are very pleased to announce this placing to EECP. The placing has been structured specifically to fit alongside the intended bank financing led by BGFI Bank Group, which is presently awaiting group credit committee approval. The timing and amounts are flexible, to enable us to accommodate other sources of financing if we wish, and to adapt to the final schedule of the NJOM-3 well on the Njonji structure in our Thali PSC area in Cameroon. We are continuing to discuss alternative rig options for this critical well, which will be targeting the appraisal and testing of 18 million barrels (pMean) of Contingent Resources and will also be penetrating additional potential reservoirs containing further prospective resources unconnected to the original two Njonji discovery wells. We are excited to be moving forward with this transformative project."
exactly Dunbot, last of the placing shares and great opportunity to grab theses shares at this level
huge uplift on next news
MM's always drop the sp on the last remaining batch as they have profited from the 0.12p placing
Great news.... I think all those shorting this company during the last 12 months or so will be panicking. £105M down to £5M
was way over done. Should see this back to £25M at least on its monthly turnover alone
Live selling tonight from 7 pm
Well all good as expected, my last post when the sp was 0.55p back in Nov was too low and we now should see us near the IPO figure of 5p, Very plausible considering no funding required and with a deceit £5M cash, OCTP are in a strong position to ride any signs of recession this year. Plenty news to follow with testing & trials in hand. Huge uplift from here. Very low free float around so expecting MM's to force sellers but hard to buy in large quantities.
Hold on to your shares...... !!! GLA
Positive update and all on track,No fund raise,£5M in bank,No Debt.4 products in the making.Trials commence next month.Reserves funding till Q4 2023
Just £6M M/C !!!.. Huge uplift on the horizon for just 0.065p a share. IPO 5p 2021
Through its outsourced model of research, OCT intends to create a portfolio of drugs with over GBP20 billion of serviceable available market, targeting a serviceable obtainable market of GBP1.55 billion with its first two drug development programmes alone.